Tekla Capital Management’s Guardant Health GH Stock Holding History

Tekla Capital Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$12.4M	Sell	346,084 -126,100	-27%	-$3.62M	0.48%	49
2023 Q1	$11.1M	Hold	472,184	–	–	0.42%	53
2022 Q4	$12.8M	Buy	472,184 +126,100	+36%	+$5.77M	0.49%	48
2022 Q3	$18.6M	Sell	346,084 -5,400	-2%	-$277K	0.76%	36
2022 Q2	$14.2M	Hold	351,484	–	–	0.56%	50
2022 Q1	$23.3M	Hold	351,484	–	–	0.82%	33
2021 Q4	$35.2M	Sell	351,484 -36,500	-9%	-$3.78M	1.13%	25
2021 Q3	$48.5M	Buy	387,984 +229,257	+144%	+$27.2M	1.56%	19
2021 Q2	$19.7M	Hold	158,727	–	–	0.64%	43
2021 Q1	$24.2M	Buy	158,727 +40,875	+35%	+$6.18M	0.83%	32
2020 Q4	$15.2M	Hold	117,852	–	–	0.53%	54
2020 Q3	$13.2M	Buy	117,852 +36,430	+45%	+$3.33M	0.49%	50
2020 Q2	$6.61M	Buy	81,422 +57,766	+244%	+$4.65M	0.25%	84
2020 Q1	$1.65M	Buy	23,656 +19,323	+446%	+$1.48M	0.07%	147
2019 Q4	$339K	Buy	+4,333	New	+$312K	0.01%	202

Other funds holding GH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Tekla Capital Management's GH Position: Q2 2023 in Review

Tekla Capital Management reduced its Guardant Health (GH) stake by 27% in Q2 2023, selling an estimated $3.62M and leaving 346,084 shares worth $12.4M. The position accounts for 0.48% of the portfolio, ranked #49.

Tekla Capital Management first reported a position in GH in Q4 2019 and has held it in 15 quarters since. The position peaked at $48.5M in Q3 2021. 301 funds tracked by Wall St. Rank hold GH as of Q2 2023.

Tekla Capital Management held 346,084 shares of Guardant Health worth $12.4M as of Q2 2023.
Tekla Capital Management sold 126,100 Guardant Health shares in Q2 2023, an estimated $3.62M.
Guardant Health made up 0.48% of Tekla Capital Management's portfolio in Q2 2023, its #49 holding.
Tekla Capital Management first reported a position in Guardant Health in Q4 2019 and has held it in 15 quarters since.
Tekla Capital Management's Guardant Health position peaked at $48.5M in Q3 2021.
301 funds tracked by Wall St. Rank held Guardant Health as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.